Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Alembic Pharmaceuticals Ltd, J B Chemicals & Pharmaceuticals Ltd, TBO Tek Ltd, Torrent Pharmaceuticals Ltd are among the other stocks to see a surge in volumes on BSE today, 30 June 2025.
Jyoti CNC Automation Ltd notched up volume of 6.05 lakh shares by 10:46 IST on BSE, a 79.9 fold spurt over two-week average daily volume of 7568 shares. The stock slipped 4.90% to Rs.1,069.25. Volumes stood at 5626 shares in the last session.
Alembic Pharmaceuticals Ltd saw volume of 2.15 lakh shares by 10:46 IST on BSE, a 35.35 fold spurt over two-week average daily volume of 6088 shares. The stock increased 12.41% to Rs.1,092.50. Volumes stood at 3761 shares in the last session.
J B Chemicals & Pharmaceuticals Ltd witnessed volume of 26053 shares by 10:46 IST on BSE, a 6.01 times surge over two-week average daily volume of 4335 shares. The stock dropped 6.14% to Rs.1,688.85. Volumes stood at 2699 shares in the last session.
TBO Tek Ltd recorded volume of 26594 shares by 10:46 IST on BSE, a 5.9 times surge over two-week average daily volume of 4505 shares. The stock gained 6.81% to Rs.1,488.20. Volumes stood at 14313 shares in the last session.
Torrent Pharmaceuticals Ltd clocked volume of 29915 shares by 10:46 IST on BSE, a 4.91 times surge over two-week average daily volume of 6093 shares. The stock lost 0.14% to Rs.3,339.85. Volumes stood at 37204 shares in the last session.
The acquisition would provide access to a fast growing India franchise, with leading brands in the chronic segment, and entry into untapped therapeutic areas like ophthalmology. It strengthens market share in the IPM for Torrent and offers operational synergies across multiple business functions.
The deal also supports platform diversification through entry into the CDMO segment with long-term potential. Additionally, it facilitates consolidation in key international markets and greater ability to scale up.
The transaction will be executed in two phases. In first phase, the company will acquire 7,44,81,519 equity shares, representing a 46.39% stake at Rs 1,600 per share, for a total consideration of Rs 11,917 crore from the promoter seller, KKR.
Additionally, the company plans to acquire up to 44,99,782 shares, representing a 2.80% stake at the same price of Rs 1,600 per share, from certain employees of JB Chemicals & Pharmaceuticals. Furthermore, the company will launch an open offer to acquire 4,17,45,264 equity shares or 26% stake at Rs 1,639.18 per share from public shareholders of JB Chemicals & Pharmaceuticals.
In second phase, the company will merge with JB Pharma through a scheme of arrangement. As per the approved by the board of directors of both companies, shareholders of JB Pharma will receive 51 shares of Torrent for every 100 shares held in JB Pharma upon completion of the merger.
Samir Mehta executive chairman, Torrent, commented: “We are pleased to have on board the JB Pharma heritage and build on the platform for the future. Torrent’s deep India presence and JB Pharma’s fast growing India business, combined with the CDMO and international footprint offers immense potential to scale both revenue and profitability. This strategic alignment furthers our goal of strengthening our presence in the Indian pharma market, and build a larger diversified global presence. Moreover, the CDMO platform provides a new long-term avenue of growth for Torrent.”
Gaurav Trehan, co-head of Asia Pacific and head of Asia Pacific Private Equity, KKR, and CEO of KKR India, said: “JB Pharma’s transformation under our stewardship is a testament to KKR’s ability to scale high-quality companies. We are proud to have collaborated with JB Pharma’s management team, led by Nikhil Chopra, to bring the breadth of KKR’s global experience and operational expertise to support the company’s organic and inorganic growth, and help JB Pharma become one of India’s fastest growing branded pharmaceutical companies. We believe the company is well-positioned for continued growth ahead and wish the team every success in its next chapter with Torrent.”
Torrent Pharma is the flagship company of the Torrent Group. It is amongst the Top 5 in the therapeutics segments of Cardiovascular (CV), Gastro Intestinal (GI), Central Nervous System (CNS) and Cosmo-Dermatology. It has 8 manufacturing facilities, of which 5 are USFDA approved.
J.B. Chemicals & Pharmaceuticals is a public listed company primarily engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations.
Jyoti CNC Automation Ltd, Karnataka Bank Ltd, Narayana Hrudayalaya Ltd and Home First Finance Company India Ltd are among the other losers in the BSE's 'A' group today, 30 June 2025.
J B Chemicals & Pharmaceuticals Ltd tumbled 6.34% to Rs 1685.25 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 37658 shares were traded on the counter so far as against the average daily volumes of 3841 shares in the past one month.
Jyoti CNC Automation Ltd crashed 5.75% to Rs 1059.75. The stock was the second biggest loser in 'A' group.On the BSE, 6.55 lakh shares were traded on the counter so far as against the average daily volumes of 13705 shares in the past one month.
Karnataka Bank Ltd lost 5.15% to Rs 197. The stock was the third biggest loser in 'A' group.On the BSE, 10.44 lakh shares were traded on the counter so far as against the average daily volumes of 90886 shares in the past one month.
Narayana Hrudayalaya Ltd shed 5.09% to Rs 2154.5. The stock was the fourth biggest loser in 'A' group.On the BSE, 65240 shares were traded on the counter so far as against the average daily volumes of 34564 shares in the past one month.
Home First Finance Company India Ltd plummeted 4.80% to Rs 1399.7. The stock was the fifth biggest loser in 'A' group.On the BSE, 10942 shares were traded on the counter so far as against the average daily volumes of 11679 shares in the past one month.